Interpace Biosciences, Inc. (IDXG)
6.025
-0.36
(-5.71%)
USD |
OTCM |
Oct 02, 16:00
Interpace Biosciences Market Cap : 33.38M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 33.38M |
| October 01, 2026 | 35.40M |
| September 30, 2026 | 35.40M |
| September 29, 2026 | 35.57M |
| September 28, 2026 | 35.57M |
| September 25, 2026 | 35.51M |
| September 23, 2026 | 35.85M |
| September 22, 2026 | 35.85M |
| September 21, 2026 | 35.73M |
| September 18, 2026 | 35.73M |
| September 17, 2026 | 35.73M |
| September 16, 2026 | 35.73M |
| September 15, 2026 | 36.01M |
| September 14, 2026 | 34.90M |
| September 11, 2026 | 36.01M |
| September 10, 2026 | 36.40M |
| September 09, 2026 | 36.01M |
| September 08, 2026 | 38.30M |
| September 04, 2026 | 38.30M |
| September 03, 2026 | 36.07M |
| September 02, 2026 | 38.67M |
| September 01, 2026 | 38.78M |
| August 31, 2026 | 41.94M |
| August 28, 2026 | 42.21M |
| August 26, 2026 | 40.17M |
| Date | Value |
|---|---|
| August 25, 2026 | 39.34M |
| August 24, 2026 | 39.61M |
| August 21, 2026 | 210.91M |
| August 20, 2026 | 222.99M |
| August 19, 2026 | 217.45M |
| August 18, 2026 | 221.61M |
| August 17, 2026 | 235.46M |
| August 14, 2026 | 229.92M |
| August 13, 2026 | 231.30M |
| August 12, 2026 | 231.30M |
| August 11, 2026 | 231.16M |
| August 10, 2026 | 235.46M |
| August 07, 2026 | 222.99M |
| August 06, 2026 | 227.15M |
| August 05, 2026 | 207.41M |
| August 04, 2026 | 225.76M |
| August 03, 2026 | 220.22M |
| July 31, 2026 | 210.11M |
| July 30, 2026 | 199.45M |
| July 29, 2026 | 214.92M |
| July 28, 2026 | 215.03M |
| July 27, 2026 | 213.93M |
| July 24, 2026 | 202.22M |
| July 23, 2026 | 200.83M |
| July 22, 2026 | 209.14M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| PD-Rx Pharmaceuticals, Inc. | 5.099M |
| Medical Marijuana, Inc. | 1.389M |
| Acro Biomedical Co. Ltd. | 1.561M |
| Stella Diagnostics, Inc. | 3.015M |
| ZeroStack Corp. | 11.81M |
Market Cap Related Metrics
| PE Ratio | 1.366 |
| PS Ratio | 0.9237 |
| PEG Ratio | 0.0314 |
| Price to Book Value | 1.436 |
| Price to Free Cash Flow | 8.135 |
| Price | 6.025 |
| Earnings Yield | 73.23% |
| PEGY Ratio | 0.0314 |
| Operating PE Ratio | 8.014 |
| Normalized PE Ratio | 1.370 |